CoChat

Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives

Open access
Abouelela, Mohamed E., Helmy, Yosra A. · 2024 · Microorganisms
Cited by 238

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Next-generation probiotics (NGPs) represent an innovative group of beneficial bacteria that are currently undergoing research and development. NGPs are designed not only for conventional use as foods or dietary supplements but are also tailored for pharmaceutical applications. Research indicates that NGPs show therapeutic promise in addressing various chronic ailments. Offering multiple advantages over conventional probiotics, NGPs present opportunities for personalized probiotic therapies, involvement in synthetic biology and gene editing, participation in combination therapies, targeted delivery methods, and application in therapeutic settings. Our review discusses the potential therapeutic effect of the NGPs, covering diverse research trajectories for NGPs, including their identification, characterization, and targeted delivery. Furthermore, this review elucidates the influence of NGPs on critical aspects of human health, specifically, gut health, immune function, and broader health outcomes. Mechanistic insights encompass the production of bioactive compounds, competitive interactions with pathogenic bacteria, the modulation of immune cell activity, and the reinforcement of the gut barrier. What is noteworthy is that the current review points out the prevalent NGP strains and their diverse sources, providing a highlight for the comprehensive framework for understanding their potential applications and their future benefits in the domain of advanced therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/microorganisms12030430

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 178

  1. Fakruddin, 2022, Next-Generation Probiotics-The Future of Biotherapeutics, Microb. Bioact., 5, 156
  2. Salas-Jara, M.J., Ilabaca, A., Vega, M., and García, A. (2016). Biofilm forming Lactobacillus: New challenges for the development of probiotics. Microorganisms, 4. · DOI · Paper page
  3. Chugh, 2020, Bioactive compounds produced by probiotics in food products, Curr. Opin. Food Sci., 32, 76, 10.1016/j.cofs.2020.02.003 · DOI · Paper page
  4. Capasso, 2021, Involvement of probiotics and postbiotics in the immune system modulation, Biologics, 1, 89, 10.3390/biologics1020006 · DOI · Paper page
  5. Shanahan, 2004, Probiotics in inflammatory bowel disease—Therapeutic rationale and role, Adv. Drug Deliv. Rev., 56, 809, 10.1016/j.addr.2003.11.003 · DOI
  6. Singh, 2021, Next-generation probiotics: A promising approach towards designing personalized medicine, Crit. Rev. Microbiol., 47, 479, 10.1080/1040841X.2021.1902940 · DOI · Paper page
  7. Steidler, 2003, Genetically engineered probiotics, Best. Pract. Res. Clin. Gastroenterol., 17, 861, 10.1016/S1521-6918(03)00072-6 · DOI
  8. Zhang, H., Duan, Y., Cai, F., Cao, D., Wang, L., Qiao, Z., Hong, Q., Li, N., Zheng, Y., and Su, M. (2022). Next-Generation Probiotics: Microflora Intervention to Human Diseases. BioMed Res. Int., 2022. · DOI
  9. Lin, 2019, Investiture of next generation probiotics on amelioration of diseases–Strains do matter, Med. Microecol., 1, 100002, 10.1016/j.medmic.2019.100002 · DOI · Paper page
  10. Danilenko, 2021, Common inflammatory mechanisms in COVID-19 and Parkinson’s diseases: The role of microbiome, pharmabiotics and postbiotics in their prevention, J. Inflamm. Res., 14, 6349, 10.2147/JIR.S333887 · DOI
  11. Aljutaily, 2020, Probiotic-enriched milk and dairy products increase gut microbiota diversity: A comparative study, Nutr. Res., 82, 25, 10.1016/j.nutres.2020.06.017 · DOI
  12. Taha-Abdelaziz, K., Singh, M., Sharif, S., Sharma, S., Kulkarni, R.R., Alizadeh, M., Yitbarek, A., and Helmy, Y.A. (2023). Intervention Strategies to Control Campylobacter at Different Stages of the Food Chain. Microorganisms, 11. · DOI
  13. Winker, 1991, A definition of the domains Archaea, Bacteria and Eucarya in terms of small subunit ribosomal RNA characteristics, Syst. Appl. Microbiol., 14, 305, 10.1016/S0723-2020(11)80303-6 · DOI · Paper page
  14. Philippe, 1996, 16S rRNA and 16S to 23S internal transcribed spacer sequence analyses reveal inter-and intraspecific Bifidobacterium phylogeny, Int. J. Syst. Evol. Microbiol., 46, 102
  15. Meshref, 2014, Screening of antagonistic activity of probiotic bacteria against some food-borne pathogens, J. Food Biosci. Technol., 4, 1
  16. Kathayat, 2022, In Vitro and In Vivo Evaluation of Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis Bb12 Against Avian Pathogenic Escherichia coli and Identification of Novel Probiotic-Derived Bioactive Peptides, Probiotics Antimicrob. Proteins, 14, 1012, 10.1007/s12602-021-09840-1 · DOI
  17. Dargahi, 2021, Immune modulatory effects of probiotic Streptococcus thermophilus on human monocytes, Biologics, 1, 396, 10.3390/biologics1030023 · DOI
  18. Helmy, 2022, Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens, Infect. Immun., 90, e0033722, 10.1128/iai.00337-22 · DOI
  19. Helmy, 2021, Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection, Gut Microbes, 13, 1857514, 10.1080/19490976.2020.1857514 · DOI
  20. Helmy, Y.A., Taha-Abdelaziz, K., Hawwas, H.A.E.-H., Ghosh, S., AlKafaas, S.S., Moawad, M.M., Saied, E.M., Kassem, I.I., and Mawad, A.M. (2023). Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics, 12. · DOI · Paper page
  21. Lamichhane, B., Mawad, A.M., Saleh, M., Kelley, W.G., Harrington, P.J., Lovestad, C.W., Amezcua, J., Sarhan, M.M., El Zowalaty, M.E., and Ramadan, H. (2024). Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections. Antibiotics, 13. · DOI · Paper page
  22. Grimoud, 2010, In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics, Anaerobe, 16, 493, 10.1016/j.anaerobe.2010.07.005 · DOI
  23. Daneshazari, 2023, Bacillus subtilis isolates from camel milk as probiotic candidates, Sci. Rep., 13, 3387, 10.1038/s41598-023-30507-0 · DOI
  24. Santivarangkna, C. (2015). Advances in Probiotic Technology, CRC Press.
  25. Pearce, 2018, Intestinal in vitro and ex vivo models to study host-microbiome interactions and acute stressors, Front. Physiol., 9, 1584, 10.3389/fphys.2018.01584 · DOI · Paper page
  26. Frece, 2005, In vivo testing of functional properties of three selected probiotic strains, World J. Microbiol. Biotechnol., 21, 1401, 10.1007/s11274-005-5741-8 · DOI
  27. Xie, 2013, Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes, Electrophoresis, 34, 2787, 10.1002/elps.201300017 · DOI · Paper page
  28. Dave, 2012, The human gut microbiome: Current knowledge, challenges, and future directions, Transl. Res., 160, 246, 10.1016/j.trsl.2012.05.003 · DOI · Paper page
  29. Chang, 2019, Next generation probiotics in disease amelioration, J. Food Drug Anal., 27, 615, 10.1016/j.jfda.2018.12.011 · DOI · Paper page
  30. Khan, 2023, Synergy and oxygen adaptation for development of next-generation probiotics, Nature, 620, 381, 10.1038/s41586-023-06378-w · DOI · Paper page
  31. Stanton, C., Desmond, C., Coakley, M., Collins, J.K., Fitzgerald, G., and Ross, R.P. (2003). Handbook of Fermented Functional Foods, CRC Press.
  32. Fuller, R. (2012). Probiotics: The Scientific Basis, Springer.
  33. Yao, 2020, Progress in microencapsulation of probiotics: A review, Compr. Rev. Food Sci. Food Saf., 19, 857, 10.1111/1541-4337.12532 · DOI · Paper page
  34. Quijano, 2011, Probiotics and prebiotics—Perspectives and challenges, J. Sci. Food Agric., 91, 1341, 10.1002/jsfa.4367 · DOI · Paper page
  35. Daniel, 2013, Probiotics from research to market: The possibilities, risks and challenges, Curr. Opin. Microbiol., 16, 284, 10.1016/j.mib.2013.06.008 · DOI · Paper page
  36. Rokka, 2010, Protecting probiotic bacteria by microencapsulation: Challenges for industrial applications, Eur. Food Res. Technol., 231, 1, 10.1007/s00217-010-1246-2 · DOI · Paper page
  37. Ranjan, A., Arora, J., Chauhan, A., Basniwal, R.K., Kumari, A., Rajput, V.D., Prazdnova, E.V., Ghosh, A., Mukerjee, N., and Mandzhieva, S.S. (2022). Advances in characterization of probiotics and challenges in industrial application. Biotechnol. Genet. Eng. Rev., 1–44. · DOI
  38. Li, S., and Zhang, Y.-X. (2023). Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics. Crit. Rev. Microbiol., 1–14. · DOI
  39. Renuka, B., and Borse, B. (2023). Novel Processing Methods for Plant-Based Health Foods, Apple Academic Press.
  40. Yunes, 2022, Lactobacilli: Legal Regulation and Prospects for New Generation Drugs, Appl. Biochem. Microbiol., 58, 652, 10.1134/S0003683822050179 · DOI
  41. Khan, S.T., and Malik, A. (2019). Health and Safety Aspects of Food Processing Technologies, Springer.
  42. Wolfe, W., Xiang, Z., Yu, X., Li, P., Chen, H., Yao, M., Fei, Y., Huang, Y., Yin, Y., and Xiao, H. (2023). The Challenge of Applications of Probiotics in Gastrointestinal Diseases. Adv. Gut Microbiome Res., 2023. · DOI
  43. Gullifa, G., Risoluti, R., Mazzoni, C., Barone, L., Papa, E., Battistini, A., Martin Fraguas, R., and Materazzi, S. (2023). Microencapsulation by a Spray Drying Approach to Produce Innovative Probiotics-Based Products Extending the Shelf-Life in Non-Refrigerated Conditions. Molecules, 28. · doi:10.3390/molecules28020860
  44. More, 2023, Duocapsule and alternative shell material to gelatin: Advancement in capsule formulation, World J. Biol. Pharm. Health Sci., 13, 221, 10.30574/wjbphs.2023.13.2.0076 · doi:10.30574/wjbphs.2023.13.2.0076
  45. Yoha, 2021, Targeted delivery of probiotics: Perspectives on research and commercialization, Probiotics Antimicrob. Proteins, 14, 15, 10.1007/s12602-021-09791-7 · DOI · Paper page
  46. Sarao, 2017, Probiotics, prebiotics, and microencapsulation: A review, Crit. Rev. Food Sci. Nutr., 57, 344, 10.1080/10408398.2014.887055 · DOI · Paper page
  47. Nezamdoost-Sani, N., Khaledabad, M.A., Amiri, S., and Khaneghah, A.M. (2023). Alginate and derivatives hydrogels in encapsulation of probiotic bacteria: An updated review. Food Biosci., 52. · DOI · Paper page
  48. Vidhyalakshmi, 2009, Encapsulation “the future of probiotics”—A review, Adv. Biol. Res., 3, 96
  49. Mawad, 2018, E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro, Appl. Microbiol. Biotechnol., 102, 10675, 10.1007/s00253-018-9417-3 · DOI
  50. Coghetto, 2016, Probiotics production and alternative encapsulation methodologies to improve their viabilities under adverse environmental conditions, Int. J. Food Sci. Nutr., 67, 929, 10.1080/09637486.2016.1211995 · DOI
  51. Torp, 2022, Optimizing oral delivery of next generation probiotics, Trends Food Sci. Technol., 119, 101, 10.1016/j.tifs.2021.11.034 · DOI · Paper page
  52. Liu, 2023, Novel Colloidal Food Ingredients: Protein Complexes and Conjugates, Annu. Rev. Food Sci. Technol., 14, 35, 10.1146/annurev-food-060721-023522 · DOI
  53. Nath, P.C., Debnath, S., Sharma, M., Sridhar, K., Nayak, P.K., and Inbaraj, B.S. (2023). Recent Advances in Cellulose-Based Hydrogels: Food Applications. Foods, 12. · DOI
  54. Mugwanda, K., Hamese, S., Van Zyl, W.F., Prinsloo, E., Du Plessis, M., Dicks, L.M., and Thimiri Govinda Raj, D.B. (2023). Recent advances in genetic tools for engineering probiotic lactic acid bacteria. Biosci. Rep., 43. · DOI
  55. Mandal, 2014, Recombinant probiotics with antimicrobial peptides: A dual strategy to improve immune response in immunocompromised patients, Drug Discov. Today, 19, 1045, 10.1016/j.drudis.2014.05.019 · DOI
  56. Torres-Sánchez, A., Ruiz-Rodríguez, A., Ortiz, P., Moreno, M.A., Ampatzoglou, A., Gruszecka-Kosowska, A., Monteoliva-Sánchez, M., and Aguilera, M. (2022). Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach. Int. J. Mol. Sci., 23. · DOI
  57. Helmy, Y.A., Kassem, I.I., Kumar, A., and Rajashekara, G. (2017). In Vitro Evaluation of the Impact of the Probiotic E. coli Nissle 1917 on Campylobacter jejuni’s Invasion and Intracellular Survival in Human Colonic Cells. Front. Microbiol., 8. · DOI
  58. Martín, R., Miquel, S., Benevides, L., Bridonneau, C., Robert, V., Hudault, S., Chain, F., Berteau, O., Azevedo, V., and Chatel, J.M. (2017). Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of F. prausnitzii as a next-generation probiotic. Front. Microbiol., 8. · DOI · Paper page
  59. Krzyżek, P., Marinacci, B., Vitale, I., and Grande, R. (2023). Extracellular Vesicles of Probiotics: Shedding Light on the Biological Activity and Future Applications. Pharmaceutics, 15. · DOI
  60. Rodovalho, V.d.R., Luz, B.S.R.d., Rabah, H., Do Carmo, F.L.R., Folador, E.L., Nicolas, A., Jardin, J., Briard-Bion, V., Blottière, H., and Lapaque, N. (2020). Extracellular vesicles produced by the probiotic Propionibacterium freudenreichii CIRM-BIA 129 mitigate inflammation by modulating the NF-κB pathway. Front. Microbiol., 11. · DOI
  61. Yu, 2016, The potential role of probiotics in cancer prevention and treatment, Nutr. Cancer, 68, 535, 10.1080/01635581.2016.1158300 · DOI
  62. Chang, 2012, Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon, J. Med. Microbiol., 61, 361, 10.1099/jmm.0.035154-0 · DOI · Paper page
  63. Torres-Maravilla, E., Boucard, A.-S., Mohseni, A.H., Taghinezhad, S.S., Cortes-Perez, N.G., and Bermúdez-Humarán, L.G. (2021). Role of gut microbiota and probiotics in colorectal cancer: Onset and progression. Microorganisms, 9. · DOI · Paper page
  64. Boesmans, 2018, Butyrate producers as potential next-generation probiotics: Safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers, Msystems, 3, e00094-18, 10.1128/mSystems.00094-18 · DOI · Paper page
  65. Thiraworawong, 2014, Anti-inflammatory Properties of Gastric-derived Lactobacillus plantarum XB 7 in the Context of Helicobacter pylori Infection, Helicobacter, 19, 144, 10.1111/hel.12105 · DOI
  66. Asoudeh-Fard, A., Barzegari, A., Dehnad, A., Bastani, S., Golchin, A., and Omidi, Y. (2017). Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signalling pathways. BioImpacts BI, 7. · DOI
  67. Maleki-Kakelar, H., Dehghani, J., Barzegari, A., Barar, J., Shirmohamadi, M., Sadeghi, J., and Omidi, Y. (2020). Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori. BioImpacts BI, 10. · DOI
  68. Mendoza, 2019, Potential effect of probiotics in the treatment of breast cancer, Oncol. Rev., 13, 134, 10.4081/oncol.2019.422 · DOI
  69. Tata, K., Ramadevi, S., Shelin, R., and Meenakshi, S. (2023). Handbook of Animal Models and Its Uses in Cancer Research, Springer.
  70. Toi, 2013, Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study, Curr. Nutr. Food Sci., 9, 194, 10.2174/15734013113099990001 · DOI · Paper page
  71. Wan, 2023, Inhibitory effect and mechanism of Lactobacillus crispatus on cervical precancerous cells Ect1/E6E7 and screening of early warning factors, Infect. Agents Cancer, 18, 5, 10.1186/s13027-023-00483-1 · DOI
  72. Aganja, R.P., Sivasankar, C., Senevirathne, A., and Lee, J.H. (2022). Salmonella as a Promising Curative Tool against Cancer. Pharmaceutics, 14. · DOI
  73. Chang, 2020, A gut butyrate-producing bacterium Butyricicoccus pullicaecorum regulates short-chain fatty acid transporter and receptor to reduce the progression of 1, 2-dimethylhydrazine-associated colorectal cancer, Oncol. Lett., 20, 327, 10.3892/ol.2020.12190 · DOI
  74. Lee, 2017, Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population, Neurogastroenterol. Motil., 29, e13003, 10.1111/nmo.13003 · DOI
  75. Bernstein, 2010, World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010, Inflamm. Bowel Dis., 16, 112, 10.1002/ibd.21048 · DOI · Paper page
  76. Hizay, 2023, Lactobacillus acidophilus regulates abnormal serotonin availability in experimental ulcerative colitis, Anaerobe, 80, 102710, 10.1016/j.anaerobe.2023.102710 · DOI
  77. Kligler, 2008, Probiotics, Am. Fam. Physician, 78, 1073
  78. Agostini, 2012, A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats, Neurogastroenterol. Motil., 24, 376-e172, 10.1111/j.1365-2982.2011.01865.x · DOI · Paper page
  79. Bonfrate, 2020, Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients, Eur. J. Clin. Investig., 50, e13201, 10.1111/eci.13201 · DOI
  80. Sawant, 2012, Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome, World J. Gastroenterol. WJG, 18, 4012, 10.3748/wjg.v18.i30.4012 · DOI · Paper page
  81. Leylabadlo, 2022, The role of gut microbiota in the treatment of irritable bowel syndrome, Rev. Med. Microbiol., 33, e89, 10.1097/MRM.0000000000000284 · DOI
  82. Mazzawi, T. (2022). Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms, 10. · DOI
  83. Mao, 2024, Blautia producta displays potential probiotic properties against dextran sulfate sodium-induced colitis in mice, Food Sci. Hum. Wellness, 13, 709, 10.26599/FSHW.2022.9250060 · DOI
  84. Liu, 2021, Blautia—A new functional genus with potential probiotic properties?, Gut Microbes, 13, 1875796, 10.1080/19490976.2021.1875796 · DOI · Paper page
  85. Hijová, E. (2023). Benefits of Biotics for Cardiovascular Diseases. Int. J. Mol. Sci., 24. · DOI
  86. Selma, M.V., Beltrán, D., Luna, M.C., Romo-Vaquero, M., García-Villalba, R., Mira, A., Espín, J.C., and Tomás-Barberán, F.A. (2017). Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin a from ellagic acid. Front. Microbiol., 8. · DOI · Paper page
  87. Zhao, Y., Zhong, X., Yan, J., Sun, C., Zhao, X., and Wang, X. (2022). Potential roles of gut microbes in biotransformation of natural products: An overview. Front. Microbiol., 13. · DOI
  88. Li, D., Li, Y., Yang, S., Lu, J., Jin, X., and Wu, M. (2022). Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics. Biomed. Pharmacother., 153. · DOI · Paper page
  89. Breton, J., Galmiche, M., and Déchelotte, P. (2022). Dysbiotic gut bacteria in obesity: An overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics. Microorganisms, 10. · DOI · Paper page
  90. Cheng, 2022, The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases, J. Food Drug Anal., 30, 1, 10.38212/2224-6614.3396 · DOI
  91. Kim, 2013, Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production, Biochem. Biophys. Res. Commun., 431, 258, 10.1016/j.bbrc.2012.12.121 · DOI · Paper page
  92. Palade, C.-M., Vulpoi, G.-A., Vulpoi, R.-A., Drug, V.L., Barboi, O.-B., and Ciocoiu, M. (2022). The Biotics Family: Current Knowledge and Future Perspectives in Metabolic Diseases. Life, 12. · DOI
  93. Mao, K., Gao, J., Wang, X., Li, X., Geng, S., Zhang, T., Sadiq, F.A., and Sang, Y. (2022). Bifidobacterium animalis subsp. lactis BB-12 has effect against obesity by regulating gut microbiota in two phases in human microbiota-associated rats. Front. Nutr., 8. · DOI
  94. Jiang, T., Li, Y., Li, L., Liang, T., Du, M., Yang, L., Yang, J., Yang, R., Zhao, H., and Chen, M. (2022). Bifidobacterium longum 070103 Fermented Milk Improve Glucose and Lipid Metabolism Disorders by Regulating Gut Microbiota in Mice. Nutrients, 14. · DOI
  95. Kim, G., Yoon, Y., Park, J.H., Park, J.W., Noh, M.-g., Kim, H., Park, C., Kwon, H., Park, J.-h., and Kim, Y. (2022). Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity. Microbiome, 10. · DOI
  96. Hao, 2022, The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice, Food Funct., 13, 9947, 10.1039/D2FO01109C · DOI
  97. Kim, J.E., Lee, J.Y., and Kang, C.-H. (2022). Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice. Foods, 11. · DOI
  98. Li, 2022, Effect of Lactobacillus fermentum hfy06 combined with arabinoxylan on reducing lipid accumulation in mice fed with high-fat diet, Oxidative Med. Cell. Longev., 2022, 1068845
  99. Zhao, 2022, Lactobacillus plantarum S9 alleviates lipid profile, insulin resistance, and inflammation in high-fat diet-induced metabolic syndrome rats, Sci. Rep., 12, 15490, 10.1038/s41598-022-19839-5 · DOI
  100. Gu, 2022, Lactobacillus paracasei IMC 502 ameliorates type 2 diabetes by mediating gut microbiota–SCFA–hormone/inflammation pathway in mice, J. Sci. Food Agric., 103, 2949, 10.1002/jsfa.12267 · DOI
  101. Miao, 2022, Lacticaseibacillus paracasei k56 attenuates high-fat diet-induced obesity by modulating the gut microbiota in mice, Probiotics Antimicrob. Proteins, 15, 844, 10.1007/s12602-022-09911-x · DOI
  102. Chen, 2022, Lactobacillus rhamnosus Strain LRH05 Intervention Ameliorated Body Weight Gain and Adipose Inflammation via Modulating the Gut Microbiota in High-Fat Diet-Induced Obese Mice, Mol. Nutr. Food Res., 66, 2100348, 10.1002/mnfr.202100348 · DOI
  103. Hosomi, 2022, Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota, Nat. Commun., 13, 4477, 10.1038/s41467-022-32015-7 · DOI · Paper page
  104. Macarulla, 2023, Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes, Front. Nutr., 9, 1084702, 10.3389/fnut.2022.1084702 · DOI
  105. Mazier, W., Le Corf, K., Martinez, C., Tudela, H., Kissi, D., Kropp, C., Coubard, C., Soto, M., Elustondo, F., and Rawadi, G. (2021). A new strain of Christensenella minuta as a potential biotherapy for obesity and associated metabolic diseases. Cells, 10. · DOI
  106. Pető, Á., Kósa, D., Szilvássy, Z., Fehér, P., Ujhelyi, Z., Kovács, G., Német, I., Pócsi, I., and Bácskay, I. (2023). Scientific and Pharmaceutical Aspects of Christensenella minuta, a Promising Next-Generation Probiotic. Fermentation, 9. · DOI
  107. Ang, W.-S., Law, J.W.-F., Letchumanan, V., Hong, K.W., Wong, S.H., Ab Mutalib, N.S., Chan, K.-G., Lee, L.-H., and Tan, L.T.-H. (2023). A Keystone Gut Bacterium Christensenella minuta—A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases. Foods, 12. · DOI
  108. Sun, 2023, Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a, Nat. Commun., 14, 7740, 10.1038/s41467-023-43622-3 · DOI · Paper page
  109. Cuffaro, B., Boutillier, D., Desramaut, J., Jablaoui, A., Werkmeister, E., Trottein, F., Waligora-Dupriet, A.-J., Rhimi, M., Maguin, E., and Grangette, C. (2023). Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity. Cells, 12. · DOI
  110. Vallianou, N.G., Kounatidis, D., Tsilingiris, D., Panagopoulos, F., Christodoulatos, G.S., Evangelopoulos, A., Karampela, I., and Dalamaga, M. (2023). The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives. Int. J. Mol. Sci., 24. · DOI
  111. Wang, 2019, Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids, Cell Rep., 26, 222, 10.1016/j.celrep.2018.12.028 · DOI · Paper page
  112. Yong, 2020, Antidepressive mechanisms of probiotics and their therapeutic potential, Front. Neurosci., 13, 1361, 10.3389/fnins.2019.01361 · DOI · Paper page
  113. Sharma, 2021, Psychobiotics: The next-generation probiotics for the brain, Curr. Microbiol., 78, 449, 10.1007/s00284-020-02289-5 · DOI
  114. Tillmann, S., Awwad, H., Eskelund, A., Treccani, G., Geisel, J., Wegener, G., and Obeid, R. (2017). Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 affect one-carbon metabolism in depressive-like rats. Proc. Neurogastroenterol. Motil., 87.
  115. Tillmann, 2018, Probiotics Affect One-Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression, Mol. Nutr. Food Res., 62, 1701070, 10.1002/mnfr.201701070 · DOI · Paper page
  116. Philippe, 2020, A probiotic mixture induces anxiolytic-and antidepressive-like effects in Fischer and maternally deprived Long Evans rats, Front. Behav. Neurosci., 14, 214
  117. Gu, 2020, Lactobacillus casei improves depression-like behavior in chronic unpredictable mild stress-induced rats by the BDNF-TrkB signal pathway and the intestinal microbiota, Food Funct., 11, 6148, 10.1039/D0FO00373E · DOI · Paper page
  118. Liu, Y.-W., Liong, M.T., Chung, Y.-C.E., Huang, H.-Y., Peng, W.-S., Cheng, Y.-F., Lin, Y.-S., Wu, Y.-Y., and Tsai, Y.-C. (2019). Effects of Lactobacillus plantarum PS128 on children with autism spectrum disorder in Taiwan: A randomized, double-blind, placebo-controlled trial. Nutrients, 11. · DOI · Paper page
  119. Kalenik, A., Kardaś, K., Rahnama, A., Sirojć, K., and Wolańczyk, T. (2021). Gut microbiota and probiotic therapy in ADHD: A review of current knowledge. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 110. · DOI · Paper page
  120. Mehrabadi, S., and Sadr, S.S. (2020). Assessment of probiotics mixture on memory function, inflammation markers, and oxidative stress in an Alzheimer’s disease model of rats. Iran. Biomed. J., 24. · DOI · Paper page
  121. Den, 2020, Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment—A meta-analysis of randomized controlled trials, Aging, 12, 4010, 10.18632/aging.102810 · DOI · Paper page
  122. Liu, 2022, Lactic acid bacteria feeding reversed the malformed eye structures and ameliorated gut microbiota profiles of Drosophila melanogaster Alzheimer’s disease model, J. Appl. Microbiol., 132, 3155, 10.1111/jam.14773 · DOI
  123. Cheng, 2022, Lactobacillus paracasei PS23 improves cognitive deficits via modulating the hippocampal gene expression and the gut microbiota in D-galactose-induced aging mice, Food Funct., 13, 5240, 10.1039/D2FO00165A · DOI
  124. Tarnaud, F., Gaucher, F., Do Carmo, F.L.R., Illikoud, N., Jardin, J., Briard-Bion, V., Guyomarc’h, F., Gagnaire, V., and Jan, G. (2020). Differential Adaptation of Propionibacterium freudenreichii CIRM-BIA129 to Cow’s Milk Versus Soymilk Environments Modulates Its Stress Tolerance and Proteome. Front. Microbiol., 11. · DOI
  125. Torii, 2011, Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children, Int. Arch. Allergy Immunol., 154, 236, 10.1159/000321110 · DOI · Paper page
  126. Kim, 2010, Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial, Pediatr. Allergy Immunol., 21, e386, 10.1111/j.1399-3038.2009.00958.x · DOI · Paper page
  127. Gueniche, 2010, Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro, Eur. J. Dermatol., 20, 731
  128. Gudadappanavar, 2017, Influence of Lactobacillus acidophilus and Lactobacillus plantarum on wound healing in male Wistar rats-an experimental study, Int. J. Appl. Basic Med. Res., 7, 233, 10.4103/ijabmr.IJABMR_329_16 · DOI · Paper page
  129. Gao, T., Wang, X., Li, Y., and Ren, F. (2023). The Role of Probiotics in Skin Health and Related Gut–Skin Axis: A Review. Nutrients, 15. · DOI · Paper page
  130. Barbosa, J.C., Machado, D., Almeida, D., Andrade, J.C., Brandelli, A., Gomes, A.M., and Freitas, A.C. (2022). Probiotics, Elsevier.
  131. Dinleyici, 2015, Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting, J. Pediatr., 91, 392, 10.1016/j.jped.2014.10.009 · DOI · Paper page
  132. Wang, 2020, Lactobacillus reuteri promotes intestinal development and regulates mucosal immune function in newborn piglets, Front. Vet. Sci., 7, 42, 10.3389/fvets.2020.00042 · DOI
  133. Nakphaichit, 2019, Protective effect of Lactobacillus reuteri KUB-AC5 against Salmonella enteritidis challenge in chickens, Benef. Microbes, 10, 43, 10.3920/BM2018.0034 · DOI
  134. Mu, Q., Tavella, V.J., and Luo, X.M. (2018). Role of Lactobacillus reuteri in human health and diseases. Front. Microbiol., 9. · DOI · Paper page
  135. Petrova, M.I., Imholz, N.C., Verhoeven, T.L., Balzarini, J., Van Damme, E.J., Schols, D., Vanderleyden, J., and Lebeer, S. (2016). Lectin-like molecules of Lactobacillus rhamnosus GG inhibit pathogenic Escherichia coli and Salmonella biofilm formation. PLoS ONE, 11. · DOI · Paper page
  136. Burkholder, 2009, Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG, Gut Pathog., 1, 14, 10.1186/1757-4749-1-14 · DOI
  137. Guan, C., Su, J., Li, F., Zhang, W., Chen, D., Chen, X., Huang, Y., Zhang, C., and Gu, R. (2023). Isolation and identification of Lacticaseibacillus rhamnosus YT and the antibacterial characteristics of its cell free supernatant and cells. preprint. · DOI
  138. Gaddawi, 2023, Effect of Lactobacillus acidophilus and Pediococcus pentosaceus on spvR gene expression of Salmonella enterica serovar Enteritidis (S. enteritidis), HIV Nurs., 23, 161
  139. Omidi, 2022, Effects of Dietary Fermented Red Grape Vinegar and Lactobacillus acidophilus on Growth Performance and Hematobiochemical and Immune Parameters in Juvenile Rainbow Trout, N. Am. J. Aquac., 84, 229, 10.1002/naaq.10232 · DOI
  140. Hossain, 2022, Inhibition of pathogenic microbes by the lactic acid bacteria Limosilactobacillus fermentum strain LAB-1 and Levilactobacillus brevis strain LAB-5 isolated from the dairy beverage borhani, Curr. Res. Nutr. Food Sci. J., 10, 928, 10.12944/CRNFSJ.10.3.10 · DOI
  141. Ren, 2022, The Probiotic Lactobacillus paracasei Ameliorates Diarrhea Cause by Escherichia coli O8 via Gut Microbiota Modulation1, Front. Nutr., 9, 878808, 10.3389/fnut.2022.878808 · DOI
  142. Soltani, N., Abbasi, S., Baghaeifar, S., Taheri, E., Jadid, M.F.S., Emami, P., Abolhasani, K., and Aslanshirzadeh, F. (2022). Antibacterial and antibiofilm activity of Lactobacillus strains secretome and extraction against Escherichia coli isolated from urinary tract infection. Biotechnol. Rep., 36. · DOI
  143. Hashemi, 2022, Antimicrobial activity of bacterial cell and cell free culture supernatant of Lactobacillus helveticus in-vitro and in a food model, J. Food Sci. Technol., 19, 1
  144. Fitzpatrick, 2011, Bacillus coagulans GBI-30 (BC30) improves indices of Clostridium difficile-induced colitis in mice, Gut Pathog., 3, 16, 10.1186/1757-4749-3-16 · DOI
  145. Nyangale, 2014, Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086, Anaerobe, 30, 75, 10.1016/j.anaerobe.2014.09.002 · DOI
  146. Han, F., Wu, G., Zhang, Y., Zheng, H., Han, S., Li, X., Cai, W., Liu, J., Zhang, W., and Zhang, X. (2020). Streptococcus thermophilus attenuates inflammation in septic mice mediated by gut microbiota. Front. Microbiol., 11. · DOI
  147. Shu, 2001, Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model, J. Pediatr. Gastroenterol. Nutr., 33, 171
  148. Silva, 2004, Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice, J. Appl. Microbiol., 97, 29, 10.1111/j.1365-2672.2004.02265.x · DOI · Paper page
  149. Gautier, T., David-Le Gall, S., Sweidan, A., Tamanai-Shacoori, Z., Jolivet-Gougeon, A., Loréal, O., and Bousarghin, L. (2021). Next-generation probiotics and their metabolites in COVID-19. Microorganisms, 9. · DOI
  150. Jiang, 2021, Pediococcus pentosaceus, a future additive or probiotic candidate, Microb. Cell Factories, 20, 45, 10.1186/s12934-021-01537-y · DOI · Paper page
  151. Qi, Y., Huang, L., Zeng, Y., Li, W., Zhou, D., Xie, J., Xie, J., Tu, Q., Deng, D., and Yin, J. (2021). Pediococcus pentosaceus: Screening and application as probiotics in food processing. Front. Microbiol., 12. · DOI
  152. Park, S.-K., Jin, H., Song, N.-E., and Baik, S.-H. (2023). Probiotic Properties of Pediococcus pentosaceus JBCC 106 and Its Lactic Acid Fermentation on Broccoli Juice. Microorganisms, 11. · DOI
  153. Ma, 2022, Engineered probiotics, Microb. Cell Factories, 21, 72, 10.1186/s12934-022-01799-0 · DOI · Paper page
  154. Praveschotinunt, 2019, Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut, Nat. Commun., 10, 5580, 10.1038/s41467-019-13336-6 · DOI · Paper page
  155. Ji, P., An, B., Jie, Z., Wang, L., Qiu, S., Ge, C., Wu, Q., Shi, J., and Huo, M. (2023). Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy. Mater. Today Bio, 18. · DOI
  156. Wang, 2023, A bioengineered probiotic for the oral delivery of a peptide Kv1. 3 channel blocker to treat rheumatoid arthritis, Proc. Natl. Acad. Sci. USA, 120, e2211977120, 10.1073/pnas.2211977120 · DOI
  157. Wu, 2022, Engineered Probiotic Lactococcus lactis for Lycopene Production against ROS Stress in Intestinal Epithelial Cells, ACS Synth. Biol., 11, 1568, 10.1021/acssynbio.1c00639 · DOI
  158. Saeidi, N., Wong, C.K., Lo, T.M., Nguyen, H.X., Ling, H., Leong, S.S.J., Poh, C.L., and Chang, M.W. (2011). Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol. Syst. Biol., 7. · DOI · Paper page
  159. Kwon, S.Y., and Min, J.-J. (2014). Gene Therapy of Cancer, Elsevier.
  160. Liang, 2019, Genetically engineered Salmonella typhimurium: Recent advances in cancer therapy, Cancer Lett., 448, 168, 10.1016/j.canlet.2019.01.037 · DOI · Paper page
  161. Nguyen, 2010, Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer, Cancer Res., 70, 18, 10.1158/0008-5472.CAN-09-3453 · DOI · Paper page
  162. Yoon, 2018, Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment, Ann. Oncol., 29, 2010, 10.1093/annonc/mdy240 · DOI
  163. Zhang, T., Zhang, J., and Duan, L. (2023). The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review. Nutrients, 15. · DOI
  164. Chua, 2017, Designer probiotics for the prevention and treatment of human diseases, Curr. Opin. Chem. Biol., 40, 8, 10.1016/j.cbpa.2017.04.011 · DOI
  165. Ulsemer, 2013, Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6, Cancer Immunol. Immunother., 62, 875, 10.1007/s00262-013-1394-x · DOI
  166. Panteli, 2016, Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses, Biotechnol. Bioeng., 113, 2474, 10.1002/bit.26006 · DOI
  167. Camacho, 2016, Engineering Salmonella as intracellular factory for effective killing of tumour cells, Sci. Rep., 6, 30591, 10.1038/srep30591 · DOI · Paper page
  168. Yoon, 2017, Application of genetically engineered Salmonella typhimurium for interferon-gamma–induced therapy against melanoma, Eur. J. Cancer, 70, 48, 10.1016/j.ejca.2016.10.010 · DOI · Paper page
  169. Yanagibashi, 2013, IgA production in the large intestine is modulated by a different mechanism than in the small intestine: Bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA+ B cells, Immunobiology, 218, 645, 10.1016/j.imbio.2012.07.033 · DOI · Paper page
  170. Langella, 2017, Use of traditional and genetically modified probiotics in human health: What does the future hold?, Microbiol. Spectr., 5, 10-1128
  171. Hinc, 2015, Recombinant Bacillus subtilis spores elicit Th1/Th17-polarized immune response in a murine model of Helicobacter pylori vaccination, Mol. Biotechnol., 57, 685, 10.1007/s12033-015-9859-0 · doi:10.1007/s12033-015-9859-0
  172. Zhou, 2015, Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores, J. Med. Microbiol., 64, 104, 10.1099/jmm.0.076430-0 · DOI
  173. Chamcha, 2015, Oral immunization with a recombinant Lactococcus lactis–expressing HIV-1 antigen on group A Streptococcus pilus induces strong mucosal immunity in the gut, J. Immunol., 195, 5025, 10.4049/jimmunol.1501243 · DOI
  174. Rosique, 2014, Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model, J. Clin. Gastroenterol., 48, S12, 10.1097/MCG.0000000000000235 · DOI
  175. Steidler, 2000, Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, Science, 289, 1352, 10.1126/science.289.5483.1352 · DOI · Paper page
  176. Hanson, 2014, Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice, Gastroenterology, 146, 210, 10.1053/j.gastro.2013.09.060 · DOI · Paper page
  177. Ricci, S., Macchia, G., Ruggiero, P., Maggi, T., Bossù, P., Xu, L., Medaglini, D., Tagliabue, A., Hammarström, L., and Pozzi, G. (2003). In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. BMC Biotechnol., 3. · DOI
  178. Caluwaerts, 2010, AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis, Oral Oncol., 46, 564, 10.1016/j.oraloncology.2010.04.008 · DOI

Cited by

See all 238

Metadata

Authors
Abouelela, M. E., & Helmy, Y. A.
Venue
Microorganisms
Publisher
MDPI AG
Published
2024-02-20
Volume
12
Issue
3
Pages
430
ISSN
2076-2607 (ISSN-L)
OpenAlex
W4391955640
Cited by
238
References
28
FWCI
46.35
Type
journal article
Language
en
Open access
gold
Funders
  • U.S. Department of Agriculture (USDA) National Institute for Food and Agriculture (NIFA) (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)
  • Center of Biomedical Research Excellence (COBRE) for Translational Chemical Biology (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)
  • National Center for Advancing Translational Sciences, National Institutes of Health (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)
  • University of Kentucky Igniting Research Collaborations program (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.